DSM-Firmenich AG (XSWX:DSFIR)
CHF 74.82 +3.98 (+5.62%) Market Cap: 18.47 Bil Enterprise Value: 21.74 Bil PE Ratio: 0 PB Ratio: 1.11 GF Score: 32/100

Full Year 2025 DSM-Firmenich AG Earnings Call Transcript

Feb 12, 2026 / 08:00AM GMT

Key Points

Positve
  • DSM-Firmenich AG (DSMFF) reported a 3% organic sales growth in 2025 despite a challenging market environment.
  • The company successfully divested its ANH business to CBC, mitigating downside risks and securing a favorable long-term supply agreement on vitamins.
  • DSM-Firmenich AG (DSMFF) maintained a stable dividend at 250, demonstrating confidence in its financial stability.
  • The company achieved a 19.6% EBITDA margin in 2025, with a trajectory towards 20% in the second half of the year.
  • DSM-Firmenich AG (DSMFF) is committed to sustainability, achieving 100% renewable energy ahead of schedule and receiving high ratings for climate and water initiatives.
Negative
  • The company experienced a cautious consumer behavior, particularly in North America, impacting its taste and health segments.
  • DSM-Firmenich AG (DSMFF) faced a decline in cash conversion, down to 10.5% from the previous year, partly due to elevated inventory levels.
  • The perfumery and beauty segment saw a margin decline due to negative mix effects and currency impacts.
  • The company did not provide a detailed 2026 outlook during the earnings call, leading to some uncertainty among investors.
  • DSM-Firmenich AG (DSMFF) is still managing the transition and separation costs from its recent divestments, which could impact short-term financials.
Dave Huizing
DSM-Firmenich AG - Senior Vice President, Investor Relations

Good morning and thank you for joining today's call. I'm sitting here with Dimitri de Fraser, our CEO, and Ralph Smits, our CEO.

This morning we published our full year 2025 results on a restated basis, together with a presentation to investors which you can find on our website. Here you can also find our disclaimers about forward-looking statements. Following Dimitri's and Rolf's opening comments, we will open the line for questions, and as usual, as a reminder, the cell site analysts who want to ask questions will need to register via the questioners link, which they can find on the website in the financial calendar.

Dmitri, the floor is yours.

Dimitri De Vreeze
DSM-Firmenich AG - Chief Executive Officer, Member of the Executive Committee

Thank you, Dave and welcome to everybody here in this call. Nice to see you yet again. A busy week for us, busy week for you. The NH call last Monday, now the full year results and you've seen that, there are a lot of numbers

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot